Oct 22, 2005

Antisoma presented Phase 2 Data for AS1404 in Lung Cancer

Antisoma is a biopharmaceutical company specializing in the development of products for the treatment of cancer. Its core activity is the pre-clinical and clinical development of these drug candidates.

Antisoma has recently announced its preliminary findings from an ongoing phase II trial of AS1404 in lung cancer. AS1404 belongs to a class of drugs called vascular disrupting agents. These drugs selectively attack tumor blood vessels, giving them broad potential against solid cancers, which depend on their blood supply to survive and grow.

Dr Mark McKeage of the University of Auckland, New Zealand, one of the Principal Investigators in the study, said: "These early data are fascinating and very encouraging." Robin Breckenridge, Global Head, Pharma Partnering Operations at Roche said: "Vascular disrupting agents represent an interesting novel approach to cancer treatment."

Antisoma's CEO Glyn Edwards said: "Lung cancer is a terrible disease that affects a huge number of patients worldwide and there is a desperate need to improve on currently available therapies.

In addition to the lung cancer study, Antisoma is conducting two other phase II studies of AS1404, in prostate and ovarian cancers.

Scott      Return to Lung Cancer Blog Main

Do You Read All Of Our Cancer Blogs?

Do you read all of the blogs published by medicineworld.org? Many of our bloggers are busy keeping you updated on the various health related topics. We publish the following blogs at this time.

Cancer blog: I manage the cancer blog with lots of help and support form other bloggers. Through this cancer blog my friends and I try to bring stories of hope for patients with cancer. The cancer blog often republishes important blog posts from other cancer related blogs at Medicineworld.org. If you are searching for a blog that covers wide variety of cancer topics, this may be the one for you.

Breast cancer blog: Breast cancer blog is run by Emily and other bloggers and they bring you the latest stories, news and events that are related to breast cancer. Increasing awareness about breast cancer among women and in the general population is the main goal of this breast cancer blog.

Lung cancer blog: Lung cancer blog is managed by Scott with the help of other bloggers. Through this blog Scott and his friends constantly remind the readers about the dangers of smoking. It's a never-ending struggle against this miserable disease with which a social stigma of smoking is associated.

Colon cancer blog: Colon cancer blog is run by Sue and other bloggers. Sue brings a personal touch to the colon cancer blog since her mother died of colon cancer few years ago. She writes about stories, research news and advances in treatment related to colon cancer.

Prostate cancer blog: Prostate cancer is the most common cancer among American men. American Cancer Society estimates that over 230,000 new cases of prostate cancer occur in the United state every year. This important blog about prostate cancer is run by Mark and other bloggers. This blog brings news, stories, and other personal observations related to prostate cancer.

Medicineworld.org publishes a diabetes watch blog and this blog is run by JoAnn other bloggers. This diabetes watch blog brings you the latest in the field of diabetes. This includes personal stories, advances in diagnosis and treatment, and other observations about diabetes. Improving awareness about diabetes is an important mission of this group.

Heart watch blog: About 13 million Americans suffer from coronary artery disease. Coronary artery disease is the leading cause of death in American men and women amounting a staggering 20 percent of all causes of death. The tremendous responsibility of running a heart blog is entrusted to Daniel. He is creating blog posts with the help and support of other bloggers.

Janet      

Lung cancer
We engage a never-ending daily struggle to understand and defeat the hidden mysteries of cancer. This is a long and laborious fight, but some moments stand out as grim reminders of the severity of the problem and ruthlessness of the enemy.